文献速递血栓与止血

预测无诱因静脉血栓栓塞后癌症风险:RIETE评分的外部验证

Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score.
PubMed 文献 · J Thromb Haemost · 2017-10-24

该研究在MVTEP研究的386例无诱因静脉血栓栓塞患者中回顾性计算RIETE癌症评分,136例(35.3%)被归为高风险,其中16例(11.8%)诊断癌症,低风险组250例中9例(3.6%)诊断癌症,比值比为3.6(95%CI 1.53-8.32),受试者工作特征曲线下面积为0.63(95%CI 0.51-0.74)。

要点

  • RIETE评分似乎能识别无诱因静脉血栓栓塞后癌症高风险亚组(约10%)。
  • 高风险组癌症诊断率11.8%,低风险组3.6%,比值比3.6(95%CI 1.53-8.32)。
  • 受试者工作特征曲线下面积为0.63(95%CI 0.51-0.74)。

核心结论

  • RIETE评分似乎能在本特定无诱因静脉血栓栓塞患者数据集中识别癌症高风险亚组(10%)。

研究设计与样本

  • 对MVTEP研究纳入的全部患者回顾性计算RIETE评分,该研究评估[¹⁸F]氟脱氧葡萄糖-正电子发射断层扫描筛查无诱因静脉血栓栓塞患者隐匿性癌症的准确性。
  • 分析纳入386例患者。

主要发现

  • 136例(35.3%)被RIETE评分归为高风险,其中16例(11.8%)诊断癌症。
  • 250例低RIETE癌症评分患者中9例(3.6%)诊断癌症,高风险组与低风险组的比值比为3.6(95%CI 1.53-8.32)。
  • 受试者工作特征曲线下面积为0.63(95%CI 0.51-0.74)。

关键数值与推荐

  • RIETE评分高风险组癌症诊断率11.8%(16/136),低风险组3.6%(9/250),比值比3.6(95%CI 1.53-8.32)。
  • 受试者工作特征曲线下面积0.63(95%CI 0.51-0.74)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Essentials Patients at high-risk of occult cancer may benefit from extensive screening. We validated the RIETE cancer score in the MVTEP study. One in three patients were classified as high-risk, 10% of whom had cancer diagnosed. The RIETE score identifies a subgroup at high risk for cancer. SUMMARY: Background Most recent trials evaluating extensive screening strategies for occult cancer in patients with unprovoked venous thromboembolism have failed, because, among other reasons, of an overall low rate of occult cancer. The RIETE investigators recently proposed a score aimed at identifying a subgroup at higher risk. Methods We retrospectively computed the RIETE score for all patients included in the MVTEP study, which evaluated the accuracy of [¹⁸F]fluorodeoxyglucose-positron emission tomography in the screening of occult cancer in patients with unprovoked venous thromboembolism. Performance of the RIETE score was assessed according to the proportion of patients classified in each risk group, and the corresponding rates of cancer diagnosis. Results Among the 386 patients included in the analysis, 136 patients (35.3%) were classified as high risk by the RIETE score. Cancer was diagnosed in 16 (11.8%) of them, whereas it was diagnosed in nine (3.6%) of the 250 patients with a low RIETE cancer score: odds ratio of 3.6 (95% confidence interval [CI] 1.53-8.32). The area under the receiver operating characteristic curve was 0.63 (95% CI 0.51-0.74). Conclusion The RIETE score seems to be able to identify a subgroup at high risk for cancer (10%) in our specific dataset of patients with unprovoked venous thromboembolism.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Bertoletti L, Robin P, Jara-Palomares L, et al. Predicting the risk of cancer after unprovoked venous thromboembolism: external validation of the RIETE score. J Thromb Haemost. 2017. PMID: 28875565. doi:10.1111/jth.13842

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。